BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/20/2022 11:01:13 AM | Browse: 239 | Download: 376
 |
Received |
|
2022-04-13 07:57 |
|
Peer-Review Started |
|
2022-04-13 08:00 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-06-11 05:54 |
|
Revised |
|
2022-06-26 02:13 |
|
Second Decision |
|
2022-08-08 03:13 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-08-18 00:07 |
|
Articles in Press |
|
2022-08-18 00:07 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-09-07 13:53 |
|
Publish the Manuscript Online |
|
2022-09-20 11:01 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Editorial |
| Article Title |
Suicidal Behavior – Advances in Clinical and Neurobiological Research and Improvement of Prevention Strategies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Thomas Sobanski, Gregor Peikert, Ulrich W Kastner and Gerd Wagner |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Thomas Sobanski, MD, Chief Doctor, Senior Lecturer, Senior Research Fellow, Department of Psychiatry, Psychotherapy, and Psychosomatic Medicine, THUERINGEN-Kliniken GmbH, 68 Rainweg, Saalfeld 07318, Germany. sobanskit@aol.com |
| Key Words |
Antidepressants; Biomarkers; Cognitive behavioral therapy; Esketamine; Prevention; Suicidal behavior |
| Core Tip |
This Editorial highlights recent developments concerning suicide prevention. According to current research, measures such as restricting access to lethal means and school-based awareness programs are the most efficacious universal prevention strategies. Novel psychological screening methods for suicidal behavior (implicit cognition, smartphone-based interventions, and real-time monitoring) have improved suicide risk assessment. Pharmacoepidemiological studies and meta-analyses support a protective role of antidepressants, lithium, and clozapine. Promising results exist for ketamine in reducing suicidal ideation. However, its suicide-preventive effect is under debate. Specific psychotherapeutic approaches for suicide attempters laying the focus on suicidal episodes proved to be efficacious for reducing suicide re-attempts. |
| Publish Date |
2022-09-20 11:01 |
| Citation |
Sobanski T, Peikert G, Kastner UW, Wagner G. Suicidal behavior-advances in clinical and neurobiological research and improvement of prevention strategies. World J Psychiatry 2022; 12(9): 1115-1126 |
| URL |
https://www.wjgnet.com/2220-3206/full/v12/i9/1115.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v12.i9.1115 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
